-
Standardization âindispensableâ in making Europe the âquantum continentâ: ETSI responds to proposed EU quantum strategy
Read more: Standardization âindispensableâ in making Europe the âquantum continentâ: ETSI responds to proposed EU quantum strategyETSI is among 168 respondents to the EUâs call for evidence on its incoming Quantum Strategy, which is aiming to make Europe take the lead in the global quantum race, with some stating that enhancing IP commercialisation mechanisms will also be key.
-
Federal Circuit upholds Modernaâs win in COVID vaccine dispute against Alnylam
Read more: Federal Circuit upholds Modernaâs win in COVID vaccine dispute against AlnylamAlnylam acted as its own lexicographer in defining keywords in patent specifications, foreclosing its own infringement allegations against Moderna, the United States Court of Appeals for the Federal Circuit has ruled.
-
Samsung may get UK interim license declaration in ZTE case next week: sole issue is whether UK judiciary has slightest respect for China
Read more: Samsung may get UK interim license declaration in ZTE case next week: sole issue is whether UK judiciary has slightest respect for ChinaContext: This week, the High Court of Justice for England & Wales (EWHC) heard Samsung’s request for a declaration of an entitlement to an interim patent license from ZTE. Opening statements were delivered on Wednesday (June 4, 2025 ip fray article), reply statements on Thursday, and Mr Justice James Mellor indicated at the end of…
-
Conditioning interim license on jurisdiction of preference is not acting in âbad faithâ: ZTE and Samsung face off in UK hearing
Read more: Conditioning interim license on jurisdiction of preference is not acting in âbad faithâ: ZTE and Samsung face off in UK hearingSamsungâs opening arguments suggest Chinese courts will produce a biased judgment, counsel for ZTE has argued.
-
Now both UPC appellate panels agree on jurisdiction over pre-UPC-start damages
Read more: Now both UPC appellate panels agree on jurisdiction over pre-UPC-start damagesContext: Earlier this year, the Unified Patent Court’s (UPC) Court of Appeal (CoA) held in Fives v. REEL that the UPC has jurisdiction over infringement claims relating to the period before the UC opened its doors (i.e., damages from periods prior to June 1, 2023) (January 17, 2025 ip fray article). The related headnote said:…
-
UPC Roundup (1 week): clarification on arbitrary territory for revocation; first Mannheim anti-antisuit injunction; new BYD case
Read more: UPC Roundup (1 week): clarification on arbitrary territory for revocation; first Mannheim anti-antisuit injunction; new BYD caseThis is a summary of developments in and around the Unified Patent Court (UPC) in the week since our May 24, 2025 UPC Roundup. 1. CD Paris: UPC revokes patent in Germany, clarifies territorial scope and invalidity grounds (Aylo Premium v. DISH Technologies) (link to LinkedIn post) The Paris seat of the Central Division (CD) revoked…
-
First-ever UPC Mannheim anti-antisuit injunction, U.S. court denies PI against Brazilian SEP enforcement: InterDigital v. Disney
Read more: First-ever UPC Mannheim anti-antisuit injunction, U.S. court denies PI against Brazilian SEP enforcement: InterDigital v. DisneyThis may even be the first anti-antisuit injunction ever to have been granted by a court based in the city of Mannheim, Germany.
-
Second UPC lawsuit filed against BYD: will Tesla throw its Chinese competitors under the bus or vice versa?
Read more: Second UPC lawsuit filed against BYD: will Tesla throw its Chinese competitors under the bus or vice versa?BYD is coming under ever more pressure from standard-essential patent assertions. Another case has been filed with the UPC’s The Hague Local Division.
Follow Us
Latest Articles
- USPTO denies ex parte reexam following earlier “settled expectations” refusal of inter partes review; Director defends discretionary powers before Federal Circuit
- Huawei announces new semiconductor law: shows independence from Western chip supply
- Global pharma company Adalvo eying U.S. expansion, says Chief IP Officer
- China Implements Pharmaceutical Test Data Protection Rules: A New Era for Drug Data Protection
- Latest amendment to Tokyo District Court’s SEP rules: global license requirement compared to latest UPC, UK, German, Brazilian approaches